Key result
Intravenous lignocaine, disopyramide, and flecainide reduced cardiac index by 9% (P<0.05), 16%, and 11% respectively in patients with uncomplicated acute myocardial infarction.
Why the study?
The comparative haemodynamic effects of three Class I antiarrhythmics in uncomplicated acute myocardial infarction were not well characterized.
What are the comparative haemodynamic effects of intravenous lignocaine, disopyramide, and flecainide in patients with uncomplicated acute myocardial infarction?
What are the comparative haemodynamic effects of intravenous lignocaine, disopyramide, and flecainide in patients with uncomplicated acute myocardial infarction?
Intravenous lignocaine, disopyramide, and flecainide all produce negative inotropic effects, reducing cardiac index and stroke volume index in patients with uncomplicated acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
May warrant haemodynamic caution with these agents in AMI; leaves open comparative effects in broader populations.
A prospective study evaluated the comparative haemodynamic effects of three Class I antiarrhythmics (lignocaine Class 1B, disopyramide Class 1A and flecainide Class 1C) in 30 patients with uncomplicated acute myocardial infarction. Three groups, each of 10 patients, were allocated to lignocaine (Group I) 1.5 mg kg-1 i.v. loading dose over 10 min followed by infusion at 3 mg kg-1 h-1, disopyramide (Group II) or flecainide (Group III), both administered as a 1.0 mg kg-1 i.v. loading bolus over 10 min followed by a 1.6 mg kg-1 h-1 infusion for 120 min. The plasma levels of each drug were in the described therapeutic range. Lignocaine decreased cardiac index (-0.3 l min-1 m-2 (9%); P less than 0.05) and stroke volume index (-5 ml m-2 (11%); P less than 0.01). Systemic blood pressure, heart rate and systemic vascular resistance index were unchanged. There was a small increase (+3 mm Hg (30%); P less than 0.01) in pulmonary artery occluded pressure (PAOP). Both disopyramide and flecainide increased systemic blood pressure; the maximum increases for mean blood pressure were +10 mm Hg (11%) and +4 mm Hg (4%) respectively. Both drugs reduced cardiac index (-0.5 l min-1 m-2 (16%): -0.4 l min-1 m-2 (11%)) and stroke volume index (-11 ml m-2 (25%): -5 ml m-2 (11%)). There were increases in heart rate (+13: +5 beats min-1) pulmonary artery occluded pressure (+2: +3 mm Hg) and systemic vascular resistance index (+696: +275 dyn s cm-5 m2).(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Silke et al. (1986) studied uncomplicated acute myocardial infarction (n=30). Lignocaine, disopyramide, and flecainide vs. Active comparators (three-arm study) was evaluated on Haemodynamic effects including cardiac index and stroke volume index (p=<0.05). Intravenous lignocaine, disopyramide, and flecainide reduced cardiac index by 9% (P<0.05), 16%, and 11% respectively in patients with uncomplicated acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: